Condition
    Preliminary
    Effectiveness 2/5

    Curcumin for Ankylosing Spondylitis

    Curcumin has a plausible anti-inflammatory mechanism and supportive evidence in rheumatoid arthritis, but almost no direct trial data in ankylosing spondylitis. It can be considered a low-risk adjunct — never a substitute for exercise, NSAIDs, or biologics, which actually prevent fusion.

    Overview

    Curcumin has a plausible anti-inflammatory mechanism and supportive evidence in rheumatoid arthritis, but almost no direct trial data in ankylosing spondylitis. It can be considered a low-risk adjunct — never a substitute for exercise, NSAIDs, or biologics, which actually prevent fusion.

    Verdict

    Mixed evidence

    Mechanistically sensible and probably safe, but the spondylitis-specific trial base is nearly empty; do not let it displace treatment that preserves spinal mobility.

    How It Works

    Curcumin inhibits NF-kB and downstream inflammatory cytokines (TNF, IL-6, IL-17) implicated in spondyloarthritis, and inhibits COX-2 — pathways overlapping with NSAID and biologic targets, at far weaker potency.

    Dosing & Protocol

    Typical dose

    Recommended dose
    500 mg twice daily bioavailable curcuminoids as an adjunct; direct evidence in ankylosing spondylitis is preliminary and mixed
    Expected timeframe
    12 weeks

    Protocol

    dose
    500 mg twice daily curcuminoids
    form
    Bioavailability-enhanced curcumin (phytosome/micellar or with piperine)
    steps
    Speak to your rheumatologist first — curcumin does not replace NSAIDs, biologics or TNF inhibitors and must not delay them,Keep prescribed treatment and your exercise/physiotherapy programme unchanged,Add 500 mg twice daily with meals containing fat,Review BASDAI and hsCRP with your clinician at 12 weeks,Discontinue if there is no measurable change, or at any sign of liver upset
    timing
    With fat-containing meals
    duration
    12 weeks before judging

    Evidence

    What the studies say

    Direct evidence is thin: a small 2015 randomized study and open-label reports suggested symptomatic improvement with curcumin in axial spondyloarthritis, but sample sizes were tiny and no trial measured structural progression. Stronger RCT evidence exists in rheumatoid arthritis and knee osteoarthritis, where curcumin (1,000–1,500 mg/day) modestly reduced pain and inflammatory markers — supporting the mechanism but not the indication. Critical context: the outcomes that matter in AS (fusion prevention, uveitis flares) have never been tested with curcumin, and smoking cessation plus biologics remain the interventions with proven structural benefit.

    No studies are yet linked to both Curcumin and Ankylosing Spondylitis.

    Safety

    Caveats

    Preliminary, mixed evidence extrapolated largely from other inflammatory arthritides. Adjunct only — untreated AS causes irreversible spinal fusion. Bleeding risk with anticoagulants/antiplatelets; stop before surgery. Avoid in active gallstone disease. Rare liver injury. Avoid therapeutic doses in pregnancy.

    Less likely to help if

    People with radiographically progressive or highly active disease needing biologic escalation; those using unenhanced turmeric powder.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.